Velan Capital Investment Management LP Next Cure, Inc. Transaction History
Velan Capital Investment Management LP
- $48.4 Million
- Q4 2024
A detailed history of Velan Capital Investment Management LP transactions in Next Cure, Inc. stock. As of the latest transaction made, Velan Capital Investment Management LP holds 25,000 shares of NXTC stock, worth $15,500. This represents 0.04% of its overall portfolio holdings.
Number of Shares
25,000Holding current value
$15,500% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding NXTC
# of Institutions
45Shares Held
14.6MCall Options Held
0Put Options Held
0-
Sofinnova Investments, Inc. Menlo Park, CA2.67MShares$1.66 Million0.17% of portfolio
-
Affinity Asset Advisors, LLC New York, NY2.3MShares$1.43 Million0.32% of portfolio
-
Citigroup Inc1.39MShares$861,2040.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA1.14MShares$707,5440.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA987KShares$612,1400.0% of portfolio
About NextCure, Inc.
- Ticker NXTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,748,800
- Market Cap $17.2M
- Description
- NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...